Home » Healthcare » Pharmaceuticals » Platelet Rich Plasma (PRP) Market

Platelet Rich Plasma (PRP) Market Growth, Future Prospects & Competitive Analysis, 2016 – 2023

Price: $4999

Published: | Report ID: 9748 | Report Format : PDF


Platelet-rich plasma (PRP) is a product that contains a large number of platelets in a small plasma volume. PRP works as a fibrin tissue adhesive with tissue sealing and hemostatic characteristics. PRP differs from platelet-poor tissue and fibrin glue because it provides a unique ability to augment the wound healing process and osteogenesis. PRP functions as a safe, biocompatible, prompt hemostatic agent and fast-tracks epidermal, epithelial, and endothelial regeneration. PRP enhances collagen synthesis, encourages angiogenesis, reduces dermal scarring, augments soft tissue healing, and reverses inhibition of glucocorticoid-induced healing. The high concentration of leukocytes in PRP offers an additional antimicrobial effect.

PRP offers a wide range of clinical healing uses in otolaryngology, general surgery, cosmetic surgery, aesthetics, burn and wound healing, cardiovascular surgery, oral and maxillofacial surgical procedures, and others. PRP has proven effective in treating chronic non-healing wounds and has been adopted as an antiangiogenic agent. In surgical procedures, PRP reduces the risk of postoperative and preoperative bleeding both at donor and recipient sites; it augments soft tissue healing and facilitates stability of grafted tissue at the recipient site owing to its adhesive and cohesive properties.

The global platelet-rich plasma market is segmented on the following bases:


  • pure platelet-rich plasma (P-PRP)
  • leukocyte-platelet-rich plasma (L-PRP)
  • Leukocyte-Platelet Rich Fibrin (L-PRF)
  • Origin
  • Allogeneic
  • Autologous
  • Homologous
  • Clinical Applications
  • General Surgery
  • Neurosurgery
  • Cosmetic Surgery and Aesthetics
  • orthopedic and spinal surgery

Others (Otorhinolaryngology-Head and Neck Surgery, Oral and Maxillofacial Surgery, Periodontal Surgery, Urology, Cardiothoracic Surgery, etc.)


  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • U.K.
    • Russia
    • Rest of Europe
  • Asia-Pacific
    • India
    • China
    • Japan
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East and Africa

Key players identified for the platelet-rich plasma market include but are not limited to:

Arthrex, Inc., Arteriocyte Medical Systems, Inc., DePuy Synthes, Inc., Biomet, Inc., Cesca Therapeutics, Inc., Dr. PRP America LLC, EmCyte Corporation, AdiStem Ltd., Exactech, Inc., Nuo Therapeutics, Inc., Regen Lab SA, Harvest Technologies Corp., and several others

This report offers the following:

  • An overview of the global markets for platelet-rich plasma
  • Market trends assessment for the period 2013-2023, with historical information for 2013 and 2014 and projections through 2023, with respective CAGRs during 2016 and 2023
  • Qualitative assessment tools such as market drivers, challenges, future prospects, major commercial events, etc.
  • Market competition scrutiny tools such as market share assessment, an attractive investment proposition, and others
  • Focus on each level of market segmentation based on product approvals, launches, and current and anticipated market dynamics.
  • A general overview of the industry structure
  • Company profiles highlight key information about the major players operating in the platelet-rich plasma market.

Frequently Asked Questions

What is the size of Platelet Rich Plasma (PRP) Market ?

The market for Platelet Rich Plasma (PRP) Market is expected to reach XX Bn in 2023.

What is the Platelet Rich Plasma (PRP) Market CAGR?

The Platelet Rich Plasma (PRP) Market is expected to see significant CAGR growth over the coming years, at XX%.

What is the Forecast period considered for Platelet Rich Plasma (PRP) Market ?

The report is forecasted from 2016-2023.

What is the base year considered for Platelet Rich Plasma (PRP) Market ?

The base year of this report is 2015

Nanoparticle Formulation Market

Report ID: 41106

Animal Drug Compounding Market

Report ID: 40870

Antibiotics Market

Report ID: 40728

Conjugation and Labeling Services Market

Report ID: 40756

Antiviral Drugs Market

Report ID: 40681

Intravitreal Injectable Market

Report ID: 7250

Pharmacogenomics Market

Report ID: 9486

Nosocomial Infection Treatment Market

Report ID: 14189

Anti-Cancer Drugs Market

Report ID: 39971

Vial Adaptors for Reconstitution Drug Market

Report ID: 15561

Congenital Disabilities Market

Report ID: 39845

Acquired Hemophilia Treatment Market

Report ID: 1124

Purchase Options

Delivery Format: Excel.
Designed for the individual purchaser.
Users located at a single corporate site or regional office.
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –


+91 6232 49 3207


24/7 Research Support


– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN